TW200718678A - Methods of preparing MEK inhibitor - Google Patents

Methods of preparing MEK inhibitor

Info

Publication number
TW200718678A
TW200718678A TW095121036A TW95121036A TW200718678A TW 200718678 A TW200718678 A TW 200718678A TW 095121036 A TW095121036 A TW 095121036A TW 95121036 A TW95121036 A TW 95121036A TW 200718678 A TW200718678 A TW 200718678A
Authority
TW
Taiwan
Prior art keywords
methods
mek inhibitor
preparing
preparing mek
phenylamino
Prior art date
Application number
TW095121036A
Other languages
Chinese (zh)
Inventor
Erwin Ayandra Irdam
Thomas Norman Nanninga
Edward Mark Davis
Howard Isaac Tjiong
Justin Kaine Weaver
Derick Dale Winkle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of TW200718678A publication Critical patent/TW200718678A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

This invention relates to methods of preparing MEK inhibitor N-[(R)-2,3-dihydroxy-propoxy]-3,4- difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide that useful for treating diseases mediated by MEK activity in mammals. The present invention provides new synthetic routes that are safe, efficient and cost effective when carried out on a commercial scale.
TW095121036A 2005-06-14 2006-06-13 Methods of preparing MEK inhibitor TW200718678A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69062005P 2005-06-14 2005-06-14

Publications (1)

Publication Number Publication Date
TW200718678A true TW200718678A (en) 2007-05-16

Family

ID=36952557

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095121036A TW200718678A (en) 2005-06-14 2006-06-13 Methods of preparing MEK inhibitor

Country Status (4)

Country Link
JP (1) JP2006348034A (en)
AR (1) AR057362A1 (en)
TW (1) TW200718678A (en)
WO (1) WO2006134469A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130113430A (en) * 2010-08-05 2013-10-15 케이스 웨스턴 리저브 유니버시티 Inhibitors of erk for developmental disorders of neuronal connectivity
CN103204822B (en) 2012-01-17 2014-12-03 上海科州药物研发有限公司 Benzoxazole compounds as protein kinase inhibitors, and preparation method and application thereof
WO2022177557A1 (en) 2021-02-17 2022-08-25 Springworks Therapeutics, Inc. Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide and uses thereof
US11084780B1 (en) 2021-02-17 2021-08-10 Springworks Therapeutics, Inc. Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
US11066358B1 (en) 2021-02-17 2021-07-20 Warner-Lambert Company Llc Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
IL304974A (en) 2021-02-17 2023-10-01 Warner Lambert Co Compositions of essentially pure form iv of n-((r)-2,3- dihydroxypropoxy)-3,4-difluoro-2- (2-fluoro-4-iodophenylamino)- benzamide and uses thereof
US11571402B2 (en) 2021-02-17 2023-02-07 Springworks Therapeutics, Inc. Dispersible formulations of N-((R)-2,3-dihydroxypropoly)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965270A (en) * 1987-05-30 1990-10-23 Beecham Group P.L.C. Purine derivatives
AU2001273498B2 (en) * 2000-07-19 2006-08-24 Warner-Lambert Company Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
EP1682495A1 (en) * 2003-10-21 2006-07-26 Warner-Lambert Company LLC Polymorphic form of n- (r)-2,3-dihydroxy-propoxy -3,4-d ifluoro-2-(2-fluoro-4-iodophenylamino)-benzamide

Also Published As

Publication number Publication date
AR057362A1 (en) 2007-11-28
WO2006134469A1 (en) 2006-12-21
JP2006348034A (en) 2006-12-28

Similar Documents

Publication Publication Date Title
TW200718678A (en) Methods of preparing MEK inhibitor
TW200621684A (en) Methods for the manufacture of biphenyl amines
CY1116754T1 (en) NITROCATECHOL PRODUCTS AS COMT INHIBITORS
HK1125359A1 (en) N-sulphonylpyrroles and their use as histone deacetylase inhibitors n-
BRPI0413124A (en) method and equipment to improve performance
ME00039B (en) Phenyl-piperazine derivatives as serotonin reuptake inhibitors
NZ596863A (en) Alkanoylamino benzamide aniline hdac inhibitor compounds
BR0109188A (en) Substituted 5-Amide Diarylamines as Mex Inhibitors
WO2007088062A3 (en) Food product comprising a proline specific protease
WO2006061712A3 (en) Use of mek inhibitors in treating abnormal cell growth
MX348030B (en) Competitive price alert system with competitive price rules engine.
DE602005008050D1 (en) TETRAHYDROPYRIDOTHIOPHENE
AR066857A1 (en) Baked Food Product
TW200744567A (en) Phenylethylamine analogs and their use for treating glaucoma
WO2006034296A3 (en) Amino-containing compounds which inhibit memapsin 2 beta-secretase activity and methods of use thereof
GR1005865B (en) NEW SIGMA LIGANDS with anti-apoptotic and/or pro-apoptotic action on the cells biochemical mechanisms and neuroprotective, anti-cancer, anti-metastatic, and anti-chronic inflammatory properties.
UA68619U (en) Red lettuce
BR0314247A (en) Condensed Palatinose In Hydrogenated Form
TW200710075A (en) Process for preparing at least one target product by partial oxidation and/or ammoxidation of propylene
NO20092134L (en) Combination product for use in the treatment of inflammatory disorders
MA33120B1 (en) METHOD OR SYSTEM USING BIOMARKERS FOR MONITORING TREATMENT
EP1476423A4 (en) Arylsulfonamidobenzylic compounds
UY30652A1 (en) N- (2-HYDROXYETHYL) -N-METHYL-4- (QUINOLIN-8-IL (1- (TIAZOL-4-ILMETIL) PIPERIDIN-4-ILIDENE) METHYL) BENZAMIDE
SG143203A1 (en) Use of agomelatine in obtaining medicaments intended for the treatment of smith-magenis syndrome
NO20061705L (en) Use of agomelatine for the manufacture of drugs intended for the treatment of bipolar disorders